Natera, Inc. is a company in the U.S. stock market and it is a holding in 55 U.S.-traded ETFs. NTRA has around 6.0M shares in the U.S. ETF market. The largest ETF holder of NTRA is the SPDR S&P Biotech ETF (XBI), with approximately 1.50M shares. Investors may also find of interest that the ETF with the largest allocation to NTRA stock is Global X Genomics & Biotechnology ETF (GNOM), with a portfolio weight of 5.78%. On average, U.S. ETFs allocate 0.39% of NTRA to their portfolios.
Additionally, NTRA is a favorite stock for Vanilla and Multi-factor ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with NTRA as a holding is the Direxion Daily S&P Biotech Bull 3X Shares (LABU), with a return of 53.89%.